Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions. (Q48786036)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Alexandre Prat

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

14

Marco Prinz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Igal Ifergan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hania Kebir

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Simone Terouz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jorge I Alvarez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Marc-André Lécuyer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Steve Gendron

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Lyne Bourbonnière

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ildiko R Dunay

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Alain Bouthillier

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Robert Moumdjian

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Adriano Fontana

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Arsalan Haqqani

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Armelle Klopstein

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Thomas Birchler

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

751-763

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22162058%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Pathology: Evolution of Pathogenetic Concepts

18 January 2020

cites work

1 reference

Multiple sclerosis: distribution of inflammatory cells in newly forming lesions

21 January 2018

1 reference

CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE.

21 January 2018

1 reference

Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

21 January 2018

1 reference

Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

21 January 2018

1 reference

Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

21 January 2018

1 reference

PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE.

21 January 2018

1 reference

Targeting the tetraspanin CD81 blocks monocyte transmigration and ameliorates EAE.

21 January 2018

1 reference

Microglia and multiple sclerosis

21 January 2018

1 reference

Microglial cell activation and proliferation precedes the onset of CNS autoimmunity

21 January 2018

1 reference

Experimental autoimmune encephalomyelitis repressed by microglial paralysis.

21 January 2018

1 reference

Hematopoietic origin of microglial and perivascular cells in brain

21 January 2018

1 reference

Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.

21 January 2018

1 reference

Local self-renewal can sustain CNS microglia maintenance and function throughout adult life.

21 January 2018

1 reference

A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them

21 January 2018

1 reference

JAM-L-mediated leukocyte adhesion to endothelial cells is regulated in cis by alpha4beta1 integrin activation

21 January 2018

1 reference

Human Thy-1 (CD90) on activated endothelial cells is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18)

21 January 2018

1 reference

CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity.

21 January 2018

1 reference

Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear

21 January 2018

1 reference

Mechanism of homophilic binding mediated by ninjurin, a novel widely expressed adhesion molecule

21 January 2018

1 reference

Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth.

21 January 2018

1 reference

Ninjurin1 is expressed in myeloid cells and mediates endothelium adhesion in the brains of EAE rats.

21 January 2018

1 reference

Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.

21 January 2018

1 reference

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

21 January 2018

1 reference

Glial cell influence on the human blood-brain barrier

21 January 2018

1 reference

Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis

21 January 2018

1 reference

Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.

21 January 2018

1 reference

B7 expression and antigen presentation by human brain endothelial cells: requirement for proinflammatory cytokines.

21 January 2018

1 reference

Dendritic cell differentiation signals induce anti-inflammatory properties in human adult microglia.

21 January 2018

1 reference

Blood monocytes consist of two principal subsets with distinct migratory properties

21 January 2018

1 reference

Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease.

21 January 2018

1 reference

A controlled trial of natalizumab for relapsing multiple sclerosis.

21 January 2018

1 reference

Natalizumab for active Crohn's disease

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

21 January 2018

1 reference

Melanoma complicating treatment with natalizumab for multiple sclerosis

21 January 2018

1 reference